WELLER T H, WITTON H M
J Exp Med. 1958 Dec 1;108(6):869-90. doi: 10.1084/jem.108.6.869.
The preparation of antigenic materials capable of specific fixation of complement in the presence of convalescent phase sera from patients with varicella and herpes zoster is described. Satisfactory antigens were obtained by the repetitive harvest and subsequent concentration of the pooled nutrient fluids from bottle cultures of human embryonic skin-muscle tissue or of monkey kidney tissue infected with varicella or herpes zoster viruses. Specific fixation of complement was also demonstrated with antigens prepared from extracts of the infected cell sheets harvested from bottle cultures. In individuals with varicella, complement-fixing antibody usually appeared in the serum 4 or 5 days after the development of the exanthem and further significant increases in titer were characteristically observed during the 2nd week of illness. The complement-fixing antibody response in herpes zoster tended to follow the same pattern as in varicella, with the exception that in sera from some individuals relatively high titers were present in the acute phase specimen. Complement-fixing antigens prepared from varicella strains or from a zoster strain reacted to essentially the same degree with convalescent sera from the homologous and the heterologous clinical entities. The varicella-zoster antigens did not fix complement in the presence of paired sera obtained from a limited number of individuals with primary infections due to herpes simplex virus or from individuals with generalized vaccinia infection. Specific inhibition in vitro of the focal cytopathic process produced by the varicella-zoster viruses was demonstrated. This was accomplished by the incorporation of the sera under test as constituents of nutrient media of the cultures, either prior to or at the time of their inoculation with virus. The neutralization of focal cytopathogenicity thus obtained was relative in degree and never absolute; it was therefore assayed by repetitive counts of the number of focal lesions per culture in the various test groups. Inhibition of varicella-zoster viral cytopathogenicity occurred in the presence of convalescent serum from either clinical entity. The results of the immunologic studies with the viruses of herpes zoster and varicella as propagated in vitro are considered as providing further evidence in support of the concept of the close relationship and probable identity of the two agents.
本文描述了在水痘和带状疱疹患者恢复期血清存在的情况下,制备能够特异性固定补体的抗原物质的方法。通过反复收集并随后浓缩来自感染水痘或带状疱疹病毒的人胚胎皮肤 - 肌肉组织或猴肾组织的瓶培养物中的合并营养液,获得了令人满意的抗原。从瓶培养物收获的感染细胞片提取物制备的抗原也证明了补体的特异性固定。在水痘患者中,补体结合抗体通常在皮疹出现后4或5天出现在血清中,并且在疾病的第2周期间通常观察到滴度进一步显著升高。带状疱疹中的补体结合抗体反应倾向于遵循与水痘相同的模式,不同之处在于一些个体的急性期标本中存在相对较高的滴度。从水痘毒株或带状疱疹毒株制备的补体结合抗原与同源和异源临床实体的恢复期血清反应的程度基本相同。水痘 - 带状疱疹抗原在从有限数量的单纯疱疹病毒原发性感染个体或全身性牛痘感染个体获得的配对血清存在下不固定补体。证明了在体外对水痘 - 带状疱疹病毒产生的局灶性细胞病变过程的特异性抑制。这是通过在接种病毒之前或之时将待测血清作为培养物营养液的成分加入来实现的。由此获得的局灶性细胞致病性的中和在程度上是相对的,而且从不完全;因此通过重复计数各个测试组中每个培养物的局灶性病变数量来进行测定。在来自任何一种临床实体的恢复期血清存在下,水痘 - 带状疱疹病毒的细胞致病性受到抑制。对体外繁殖的带状疱疹和水痘病毒进行的免疫学研究结果被认为进一步支持了这两种病原体密切相关且可能相同这一概念。